Key clinical point: Infections add to the risk of a cardiovascular disease event in HIV-infected individuals.
Major finding: HCV coinfection increased the risk of developing a CVD event in the HIV-infected patients (OR, 2.84).
Study details: A retrospective study of 823 patients at a single institution.
Disclosures: The authors reported that they had no conflicts.
Genebat M. et al. Antiviral Res. 2019 Sep;169:104527.